Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2025-12-28 @ 7:25 AM
Study NCT ID:
NCT01464034
Status:
TERMINATED
Last Update Posted:
2022-08-01
First Post:
2011-10-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
Criterium, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11
Start Date Type:
None
Primary Completion Date:
2020-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-19
First Submit QC Date:
None
Study First Post Date:
2011-11-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-28
Last Update Post Date:
2022-08-01
Last Update Post Date Type:
ACTUAL